A hearing has been scheduled in November for the appeal by North American Scientific Inc. on its delisting from The Nasdaq Stock Market. The Chatsworth-based maker of radiation therapy products will continue to appear on The Nasdaq Global Market until the Nasdaq Listing Qualifications Panel makes a final decision after the Nov. 29 hearing. In September, Nasdaq informed North American Scientific that it was ineligible for listing on the Global Market for failing to comply with the minimum $10 million stockholders’ equity requirement and the minimum $50 million market value of listed securities.